Market Overview

Trade RMED stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
10/22/18PiperJaffrayInitiates Coverage OnOverweight23.0
10/22/18Cantor FitzgeraldInitiates Coverage OnOverweight21.0
10/22/18SunTrust Robinson HumphreyInitiates Coverage OnBuy16.0

Earnings View Earnings

Q3 2018 EST Actual Surprise
EPS: -0.35 -0.59 -0.24
Rev: 2.00M 2.06M 64.00K
Q4 2018 EST Actual Surprise
EPS: -0.38 Expected
2019-02-25
Rev: 2.70M

Company Profile